Journal of Cerebrovascular and Endovascular Neurosurgery

Korean Society of Cerebravascular Surgeons (대한뇌혈관외과학회)
권호 표지

Effects of Atorvastatin on the Induction of Experimental Cerebral Aneurysm in a High Lipid Diet Rat Model

  • Lim, Jeong-Kyu (Department of Neurosurgery, Daejeon St Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Yeo, In-Sung (Department of Neurosurgery, Daejeon St Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Yi, Jin-Seok (Department of Neurosurgery, Daejeon St Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Hyung-Jin (Department of Neurosurgery, Daejeon St Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Yang, Ji-Ho (Department of Neurosurgery, Daejeon St Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Il-Woo (Department of Neurosurgery, Daejeon St Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Published : 2010.09.30
⟨ Previous Next ⟩

Abstract

Objective : Previously, we reported that a high lipid diet significantly increases the induction rate of cerebral aneurysm (CA) formation in an experimentally induced CA rat model, suggesting that hypercholesterolemia with chronic inflammation leads to aneurysm formation. To elucidate the role of hypercholesterolemia in CA formation, experimentally induced CA was evaluated in rats fed a high lipid diet and treated with low and high doses of atorvastatin. Methods : Thirty-seven, 7-week-old male Sprague-Dawley rats underwent a CA induction procedure. The control animals (n = 11) were fed a normal diet, and the experimental animals (n = 26) were fed a diet containing high lipid content for 3 months. The experimental group comprised a high-dose atorvastatin group (20 mg/kg/day, n = 15) and low-dose atorvastatin group (1 mg/kg/day, n = 11). Three months after the operation, induction of CA formation in the three groups was analyzed. Results : Induced CA formation was 67%, 63%, and 36% in the control, high lipid/high atovastatin, and high lipid/low atovastatin group, respectively. The differences resulting from high-dose and low-dose atorvastatin were significant (Pearson k2, P = 0.028 and 0.029, respectively). Conclusions : A high lipid diet can significantly increase induction of CA formation. However, the lack of decreased induction in atorvastatin-treated animals suggests that high and low doses of atorvastatin do not inhibit the potential effects of hypercholesterolemia on CA formation. Further studies, such as those utilizing apolipoprotein E knockout mice, are necessary to elucidate the exact role of hypercholesterolemia in the pathophysiology of CA.

Keywords

References

  1. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N: Simvastatin suppresses the progression of experimentally induced cerebral aneurysm in rats. Stroke 39:1276-1285, 2008 https://doi.org/10.1161/STROKEAHA.107.503086
  2. Aoki T, Kataoka H, Moriwaki T, Nozaki K, Hashimoto N: Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysm. Stroke 38:2337-2345, 2007 https://doi.org/10.1161/STROKEAHA.107.481838
  3. Choi HW, Yi JS, Lee HJ, Yang JH, Lee IW: Difference in induction rate of experimental cerebral aneurysm according to high salt, high lipid and normal diet. Korean J CerebrovasculSurg 8:102-106, 2006
  4. Choi YM, Yi JS, Lee HJ, Yang JH, Lee IW: Apolipoprotein E expression in experimentally induced intracranial aneurysms of the rats. J Korean NeurosurgSoc 39:46-51, 2006
  5. Hashimoto N, Handa H, Hazama F: Experimentally induced cerebral aneurysms in rats. Surg Neurol 10:3-8, 1978
  6. Holmes DR, Lopez-Candales A, Liao S, Thompson RW: Smooth muscle cell apoptosis and p53 expression in human abdominal aortic aneurysms. Ann NY Acad Sci 800:286-287, 1996 https://doi.org/10.1111/j.1749-6632.1996.tb33334.x
  7. Kalyanasundaram A, Elmore JR, Manazer JR, Golden A, Franklin DP, Galt SW et al: Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg 43:117-124, 2006 https://doi.org/10.1016/j.jvs.2005.08.007
  8. Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H: Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 29:181-188, 1998 https://doi.org/10.1161/01.STR.29.1.181
  9. Libby P: Inflammation in atherosclerosis. Nature 420:868-874, 2002 https://doi.org/10.1038/nature01323
  10. Miyazawa N, Akiyama I , Yamagata Z: Risk factors for growth of unruptured intracranial aneurysms: follow-up study by serial 0.5-T magnetic resonance angiography. Neurosurg 58:1047-1053, 2006 https://doi.org/10.1227/01.NEU.0000217366.02567.D2
  11. Nakatani H, Hashimoto N, Kang Y, Yamazoe N, Kikuchi H, Yamaguchi S et al: Cerebral blood flow patterns at major vessel bifurcations and aneurysms in rats. J Neurosurg 74:258-262, 1991 https://doi.org/10.3171/jns.1991.74.2.0258
  12. Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ et al: Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol. 15:678-682, 1995 https://doi.org/10.1161/01.ATV.15.5.678
  13. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 362:801-809, 1993 https://doi.org/10.1038/362801a0
  14. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D et al: Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice Ann Surg 241:92-101, 2005
  15. Thompson RW, Parks WC: Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci 800:157-174, 1996 https://doi.org/10.1111/j.1749-6632.1996.tb33307.x
  16. Zhang SH, Reddick RL, Piedrahita JA Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471, 1992 https://doi.org/10.1126/science.1411543